2尿,-2

Jimmy Ho Cheung Mak1, David Tak-Wai Lui1, Carol Ho-Yi Fong1

  • 1Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Clinical endocrinology
|December 21, 2023
PubMed
概括

在2型糖尿病患者中,达帕格利弗洛辛治疗显著降低了血清中血栓素-2 (TSP2) 水平,这是肝纤维化的潜在生物标志物. 这种降低与改善的肝硬度相关,表明TSP2